We serve Chemical Name:6-nitro-1H-quinoxalin-2-one CAS:25652-34-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-nitro-1H-quinoxalin-2-one
CAS.NO:25652-34-0
Synonyms:6-nitro-2-quinoxalinol;6-nitroquinoxalin-2(1)-one;6-Nitro-1H-chinoxalin-2-on;6-nitroquinoxaline-2(1H)-one;6-nitroquinoxalin-2-ol;6-nitro-2-quinoxalone;6-Nitroquinoxalin-2-one;6-nitroquinoxalin-2(1H)-one
Molecular Formula:C8H5N3O3
Molecular Weight:191.14400
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:91.57000
Exact Mass:191.03300
LogP:1.35450
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-nitro-2-quinoxalinol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-nitroquinoxalin-2(1H)-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-nitroquinoxaline-2(1H)-one Use and application,6-nitroquinoxalin-2(1H)-one technical grade,usp/ep/jp grade.
Related News: Their pharmacological activity plays a direct role in the diagnosis, cure, mitigation, treatment, or prevention of disease. 6-nitro-1H-quinoxalin-2-one manufacturer Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement. 6-nitro-1H-quinoxalin-2-one supplier Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for cancer and immune disorders. 6-nitro-1H-quinoxalin-2-one vendor The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen��s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination. 6-nitro-1H-quinoxalin-2-one factory Today’s decisions represent progress in our continued efforts to make a difference in this pandemic on a global scale, Kathy Wengel, J&J’s chief global supply chain officer, said in the statement.
